

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.84495300 |
| 2 | synaptic vesicle exocytosis (GO:0016079) | 5.58196448 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.48997720 |
| 4 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.41741779 |
| 5 | synaptic vesicle maturation (GO:0016188) | 5.33135619 |
| 6 | protein localization to synapse (GO:0035418) | 5.30392230 |
| 7 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.13994934 |
| 8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.08408829 |
| 9 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.80696155 |
| 10 | behavioral response to nicotine (GO:0035095) | 4.80432317 |
| 11 | vocalization behavior (GO:0071625) | 4.77425713 |
| 12 | glutamate secretion (GO:0014047) | 4.70824453 |
| 13 | locomotory exploration behavior (GO:0035641) | 4.61740797 |
| 14 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.56411534 |
| 15 | regulation of synaptic vesicle transport (GO:1902803) | 4.47023219 |
| 16 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.46084698 |
| 17 | * rhodopsin mediated signaling pathway (GO:0016056) | 4.42979896 |
| 18 | * regulation of rhodopsin mediated signaling pathway (GO:0022400) | 4.41453141 |
| 19 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.28396487 |
| 20 | striatum development (GO:0021756) | 4.27588876 |
| 21 | regulation of synapse structural plasticity (GO:0051823) | 4.24494011 |
| 22 | neurotransmitter secretion (GO:0007269) | 4.23402969 |
| 23 | cellular potassium ion homeostasis (GO:0030007) | 4.16760636 |
| 24 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.16345144 |
| 25 | positive regulation of synapse maturation (GO:0090129) | 4.12740495 |
| 26 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.05280766 |
| 27 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.04132054 |
| 28 | neuron-neuron synaptic transmission (GO:0007270) | 4.04010331 |
| 29 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.92575488 |
| 30 | detection of light stimulus involved in visual perception (GO:0050908) | 3.92575488 |
| 31 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.91515267 |
| 32 | retinal rod cell development (GO:0046548) | 3.82415274 |
| 33 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.81231619 |
| 34 | exploration behavior (GO:0035640) | 3.80181724 |
| 35 | retinal cone cell development (GO:0046549) | 3.80064369 |
| 36 | positive regulation of neurotransmitter transport (GO:0051590) | 3.79272375 |
| 37 | long-term synaptic potentiation (GO:0060291) | 3.79170271 |
| 38 | synaptic transmission, glutamatergic (GO:0035249) | 3.78466993 |
| 39 | serotonin metabolic process (GO:0042428) | 3.77957403 |
| 40 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.77834436 |
| 41 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.77834436 |
| 42 | postsynaptic membrane organization (GO:0001941) | 3.76153138 |
| 43 | positive regulation of membrane potential (GO:0045838) | 3.75882392 |
| 44 | behavioral response to cocaine (GO:0048148) | 3.74265888 |
| 45 | synaptic transmission, dopaminergic (GO:0001963) | 3.71835189 |
| 46 | prepulse inhibition (GO:0060134) | 3.68574924 |
| 47 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.68305530 |
| 48 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.68014251 |
| 49 | synaptic vesicle endocytosis (GO:0048488) | 3.66805343 |
| 50 | response to histamine (GO:0034776) | 3.66190736 |
| 51 | neuronal action potential propagation (GO:0019227) | 3.63802211 |
| 52 | sodium ion export (GO:0071436) | 3.63514679 |
| 53 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.61839672 |
| 54 | transmission of nerve impulse (GO:0019226) | 3.60432198 |
| 55 | neuron cell-cell adhesion (GO:0007158) | 3.59965328 |
| 56 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.59414886 |
| 57 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.58753964 |
| 58 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.58134829 |
| 59 | regulation of neurotransmitter secretion (GO:0046928) | 3.57915183 |
| 60 | primary amino compound metabolic process (GO:1901160) | 3.56108375 |
| 61 | glutamate receptor signaling pathway (GO:0007215) | 3.55631886 |
| 62 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.55209282 |
| 63 | membrane hyperpolarization (GO:0060081) | 3.53151781 |
| 64 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.51761120 |
| 65 | photoreceptor cell development (GO:0042461) | 3.48964542 |
| 66 | long-term memory (GO:0007616) | 3.47904021 |
| 67 | regulation of postsynaptic membrane potential (GO:0060078) | 3.46395562 |
| 68 | neurotransmitter transport (GO:0006836) | 3.46344613 |
| 69 | regulation of neurotransmitter transport (GO:0051588) | 3.43763977 |
| 70 | nucleobase catabolic process (GO:0046113) | 3.42753398 |
| 71 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.42329704 |
| 72 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.41704273 |
| 73 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.40793260 |
| 74 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.40386496 |
| 75 | neurofilament cytoskeleton organization (GO:0060052) | 3.38075903 |
| 76 | dendritic spine morphogenesis (GO:0060997) | 3.37036466 |
| 77 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.35972019 |
| 78 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.29370688 |
| 79 | eye photoreceptor cell development (GO:0042462) | 3.28875426 |
| 80 | neuronal action potential (GO:0019228) | 3.28601399 |
| 81 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.27743639 |
| 82 | innervation (GO:0060384) | 3.27408381 |
| 83 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.26951621 |
| 84 | dopamine receptor signaling pathway (GO:0007212) | 3.26792033 |
| 85 | regulation of neurotransmitter uptake (GO:0051580) | 3.24583790 |
| 86 | layer formation in cerebral cortex (GO:0021819) | 3.24096757 |
| 87 | behavioral defense response (GO:0002209) | 3.23074078 |
| 88 | behavioral fear response (GO:0001662) | 3.23074078 |
| 89 | regulation of synaptic plasticity (GO:0048167) | 3.21895193 |
| 90 | positive regulation of synaptic transmission (GO:0050806) | 3.18972786 |
| 91 | regulation of synapse maturation (GO:0090128) | 3.17955361 |
| 92 | protein neddylation (GO:0045116) | 3.15551933 |
| 93 | activation of protein kinase A activity (GO:0034199) | 3.14974228 |
| 94 | membrane depolarization during action potential (GO:0086010) | 3.13928321 |
| 95 | response to auditory stimulus (GO:0010996) | 3.13269385 |
| 96 | auditory behavior (GO:0031223) | 3.12401066 |
| 97 | regulation of vesicle fusion (GO:0031338) | 3.12256443 |
| 98 | cell communication by electrical coupling (GO:0010644) | 3.09206868 |
| 99 | regulation of neurotransmitter levels (GO:0001505) | 3.06014982 |
| 100 | startle response (GO:0001964) | 3.05973778 |
| 101 | long term synaptic depression (GO:0060292) | 3.05609891 |
| 102 | photoreceptor cell maintenance (GO:0045494) | 3.05093225 |
| 103 | potassium ion homeostasis (GO:0055075) | 3.04847712 |
| 104 | gamma-aminobutyric acid transport (GO:0015812) | 3.04281567 |
| 105 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.02680028 |
| 106 | L-fucose catabolic process (GO:0042355) | 3.02268707 |
| 107 | fucose catabolic process (GO:0019317) | 3.02268707 |
| 108 | L-fucose metabolic process (GO:0042354) | 3.02268707 |
| 109 | * regulation of voltage-gated calcium channel activity (GO:1901385) | 3.01773298 |
| 110 | behavioral response to ethanol (GO:0048149) | 3.00273415 |
| 111 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 2.98832831 |
| 112 | membrane depolarization (GO:0051899) | 2.97738015 |
| 113 | synaptic transmission (GO:0007268) | 2.97208909 |
| 114 | negative regulation of appetite (GO:0032099) | 2.97069095 |
| 115 | negative regulation of response to food (GO:0032096) | 2.97069095 |
| 116 | presynaptic membrane assembly (GO:0097105) | 2.95997863 |
| 117 | negative regulation of heart rate (GO:0010459) | 2.95917965 |
| 118 | response to pheromone (GO:0019236) | 2.95909712 |
| 119 | fear response (GO:0042596) | 2.95753330 |
| 120 | neuromuscular process controlling balance (GO:0050885) | 2.94155816 |
| 121 | response to amphetamine (GO:0001975) | 2.91956285 |
| 122 | presynaptic membrane organization (GO:0097090) | 2.89541957 |
| 123 | dopamine transport (GO:0015872) | 2.85227490 |
| 124 | detection of calcium ion (GO:0005513) | 2.81744615 |
| 125 | synapse assembly (GO:0007416) | 2.77909220 |
| 126 | neuromuscular synaptic transmission (GO:0007274) | 2.76002858 |
| 127 | dopamine biosynthetic process (GO:0042416) | 2.71544041 |
| 128 | cellular ketone body metabolic process (GO:0046950) | 2.71072172 |
| 129 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.64811731 |
| 130 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.64146911 |
| 131 | cyclic nucleotide catabolic process (GO:0009214) | 2.63668775 |
| 132 | urinary tract smooth muscle contraction (GO:0014848) | 2.63199981 |
| 133 | glycerophospholipid catabolic process (GO:0046475) | 2.61063031 |
| 134 | indole-containing compound metabolic process (GO:0042430) | 2.60247980 |
| 135 | cellular potassium ion transport (GO:0071804) | 2.59147848 |
| 136 | potassium ion transmembrane transport (GO:0071805) | 2.59147848 |
| 137 | action potential (GO:0001508) | 2.57593477 |
| 138 | protein polyglutamylation (GO:0018095) | 2.56087011 |
| 139 | glycosphingolipid biosynthetic process (GO:0006688) | 2.55706193 |
| 140 | adult behavior (GO:0030534) | 2.54889192 |
| 141 | proline transport (GO:0015824) | 2.54556835 |
| 142 | central nervous system myelination (GO:0022010) | 2.54112941 |
| 143 | axon ensheathment in central nervous system (GO:0032291) | 2.54112941 |
| 144 | cAMP catabolic process (GO:0006198) | 2.51565941 |
| 145 | positive regulation of amino acid transport (GO:0051957) | 2.51513971 |
| 146 | negative regulation of telomere maintenance (GO:0032205) | 2.51136966 |
| 147 | sequestering of actin monomers (GO:0042989) | 2.51076669 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.18885099 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.00194561 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.12004969 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.10377064 |
| 5 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.97248297 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.83227234 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.82317812 |
| 8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.67339658 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.64990902 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.64990902 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.64345897 |
| 12 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.55842969 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.50883443 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.50747755 |
| 15 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.47666244 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.46653924 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.45147472 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.32368925 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.30582047 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.27471166 |
| 21 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.25269606 |
| 22 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.20459925 |
| 23 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.18352982 |
| 24 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.16622090 |
| 25 | VDR_22108803_ChIP-Seq_LS180_Human | 2.14566268 |
| 26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.14243123 |
| 27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.13062988 |
| 28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.84958958 |
| 29 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.83413817 |
| 30 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.81711148 |
| 31 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.81560082 |
| 32 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.81521608 |
| 33 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.80597244 |
| 34 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.78055916 |
| 35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.74469494 |
| 36 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.69548284 |
| 37 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.59378493 |
| 38 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.54310786 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.52857794 |
| 40 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.49542913 |
| 41 | FUS_26573619_Chip-Seq_HEK293_Human | 1.46524403 |
| 42 | EWS_26573619_Chip-Seq_HEK293_Human | 1.40869904 |
| 43 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.36910007 |
| 44 | P300_19829295_ChIP-Seq_ESCs_Human | 1.36416520 |
| 45 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.35959270 |
| 46 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.35446880 |
| 47 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.34819742 |
| 48 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.34746809 |
| 49 | AR_19668381_ChIP-Seq_PC3_Human | 1.34110810 |
| 50 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.33598354 |
| 51 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.32181740 |
| 52 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.31555562 |
| 53 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.30183572 |
| 54 | STAT3_23295773_ChIP-Seq_U87_Human | 1.29212399 |
| 55 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.29189364 |
| 56 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.28830528 |
| 57 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.28372286 |
| 58 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.28093800 |
| 59 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.26335394 |
| 60 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.25966061 |
| 61 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.25360773 |
| 62 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25360773 |
| 63 | AR_25329375_ChIP-Seq_VCAP_Human | 1.24946844 |
| 64 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.24158570 |
| 65 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.24053034 |
| 66 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.23451275 |
| 67 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.22419831 |
| 68 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22096277 |
| 69 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.21409635 |
| 70 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.21368926 |
| 71 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.19876285 |
| 72 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.19002169 |
| 73 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.17678994 |
| 74 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.15582987 |
| 75 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14494223 |
| 76 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.12802417 |
| 77 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.12131273 |
| 78 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.12065727 |
| 79 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.11700387 |
| 80 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11270942 |
| 81 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.11020536 |
| 82 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.09935133 |
| 83 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.09569784 |
| 84 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.08242831 |
| 85 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.08056295 |
| 86 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.06359846 |
| 87 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06317097 |
| 88 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06080407 |
| 89 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.05932620 |
| 90 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.05775942 |
| 91 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.05594591 |
| 92 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.02870934 |
| 93 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.02448285 |
| 94 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.02137247 |
| 95 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.01439051 |
| 96 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.01439051 |
| 97 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.00825210 |
| 98 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.00431828 |
| 99 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00316351 |
| 100 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.00255164 |
| 101 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99929687 |
| 102 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.99595631 |
| 103 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.99251831 |
| 104 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99085897 |
| 105 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.98399954 |
| 106 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.97928683 |
| 107 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.97854325 |
| 108 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97839600 |
| 109 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.97264670 |
| 110 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.96790544 |
| 111 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.96390828 |
| 112 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.95240833 |
| 113 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.94467558 |
| 114 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.94258000 |
| 115 | JUN_21703547_ChIP-Seq_K562_Human | 0.94183872 |
| 116 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93812635 |
| 117 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.93143976 |
| 118 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92790077 |
| 119 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.92453370 |
| 120 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92005298 |
| 121 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.89983477 |
| 122 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.89899040 |
| 123 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.88031220 |
| 124 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.86403202 |
| 125 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.86403202 |
| 126 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85937154 |
| 127 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.85778823 |
| 128 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.85502128 |
| 129 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.84901697 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.27525645 |
| 2 | MP0005551_abnormal_eye_electrophysiolog | 4.02309803 |
| 3 | MP0003880_abnormal_central_pattern | 4.01901626 |
| 4 | MP0002822_catalepsy | 3.84386259 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 3.66112351 |
| 6 | MP0004270_analgesia | 3.12274542 |
| 7 | MP0009745_abnormal_behavioral_response | 3.10372835 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.01930829 |
| 9 | * MP0002064_seizures | 2.85978586 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.79080342 |
| 11 | * MP0009046_muscle_twitch | 2.73150329 |
| 12 | MP0003011_delayed_dark_adaptation | 2.56477676 |
| 13 | MP0006072_abnormal_retinal_apoptosis | 2.55167338 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.54305514 |
| 15 | MP0002572_abnormal_emotion/affect_behav | 2.52958318 |
| 16 | MP0001486_abnormal_startle_reflex | 2.50665743 |
| 17 | MP0002272_abnormal_nervous_system | 2.50043240 |
| 18 | MP0005253_abnormal_eye_physiology | 2.44945409 |
| 19 | MP0002734_abnormal_mechanical_nocicepti | 2.40670453 |
| 20 | MP0001984_abnormal_olfaction | 2.21585353 |
| 21 | MP0002736_abnormal_nociception_after | 2.16301775 |
| 22 | MP0002090_abnormal_vision | 2.02889672 |
| 23 | MP0009780_abnormal_chondrocyte_physiolo | 1.91349804 |
| 24 | MP0008877_abnormal_DNA_methylation | 1.91343408 |
| 25 | MP0000569_abnormal_digit_pigmentation | 1.90432628 |
| 26 | MP0001501_abnormal_sleep_pattern | 1.85519170 |
| 27 | * MP0002067_abnormal_sensory_capabilities | 1.84047188 |
| 28 | MP0008569_lethality_at_weaning | 1.81916696 |
| 29 | MP0002909_abnormal_adrenal_gland | 1.81623850 |
| 30 | MP0005646_abnormal_pituitary_gland | 1.78125456 |
| 31 | MP0002735_abnormal_chemical_nociception | 1.76526220 |
| 32 | MP0003136_yellow_coat_color | 1.73131419 |
| 33 | MP0001529_abnormal_vocalization | 1.70253453 |
| 34 | MP0001502_abnormal_circadian_rhythm | 1.66377952 |
| 35 | MP0001970_abnormal_pain_threshold | 1.65764598 |
| 36 | MP0005386_behavior/neurological_phenoty | 1.62793133 |
| 37 | MP0004924_abnormal_behavior | 1.62793133 |
| 38 | MP0002184_abnormal_innervation | 1.61288596 |
| 39 | MP0002229_neurodegeneration | 1.60114681 |
| 40 | MP0003879_abnormal_hair_cell | 1.57607957 |
| 41 | * MP0002882_abnormal_neuron_morphology | 1.56094450 |
| 42 | MP0004811_abnormal_neuron_physiology | 1.54225930 |
| 43 | MP0002557_abnormal_social/conspecific_i | 1.51892635 |
| 44 | MP0004233_abnormal_muscle_weight | 1.51550456 |
| 45 | MP0002733_abnormal_thermal_nociception | 1.51230071 |
| 46 | MP0001440_abnormal_grooming_behavior | 1.50866933 |
| 47 | MP0002638_abnormal_pupillary_reflex | 1.50857794 |
| 48 | MP0001485_abnormal_pinna_reflex | 1.48796654 |
| 49 | MP0005195_abnormal_posterior_eye | 1.45133978 |
| 50 | MP0002102_abnormal_ear_morphology | 1.43449286 |
| 51 | MP0000751_myopathy | 1.34309699 |
| 52 | MP0000013_abnormal_adipose_tissue | 1.31905876 |
| 53 | MP0004885_abnormal_endolymph | 1.27596046 |
| 54 | MP0005394_taste/olfaction_phenotype | 1.27294485 |
| 55 | MP0005499_abnormal_olfactory_system | 1.27294485 |
| 56 | MP0005084_abnormal_gallbladder_morpholo | 1.27091877 |
| 57 | MP0000955_abnormal_spinal_cord | 1.26719961 |
| 58 | MP0003787_abnormal_imprinting | 1.26397494 |
| 59 | MP0008875_abnormal_xenobiotic_pharmacok | 1.24958157 |
| 60 | * MP0002066_abnormal_motor_capabilities/c | 1.23961999 |
| 61 | MP0002752_abnormal_somatic_nervous | 1.20453673 |
| 62 | MP0004858_abnormal_nervous_system | 1.19609175 |
| 63 | MP0000778_abnormal_nervous_system | 1.19540372 |
| 64 | MP0002653_abnormal_ependyma_morphology | 1.19453246 |
| 65 | MP0003329_amyloid_beta_deposits | 1.19203337 |
| 66 | MP0004215_abnormal_myocardial_fiber | 1.17830924 |
| 67 | MP0010386_abnormal_urinary_bladder | 1.17765807 |
| 68 | MP0003122_maternal_imprinting | 1.16895745 |
| 69 | MP0001188_hyperpigmentation | 1.15437000 |
| 70 | MP0003633_abnormal_nervous_system | 1.14533771 |
| 71 | MP0004142_abnormal_muscle_tone | 1.12928589 |
| 72 | MP0006276_abnormal_autonomic_nervous | 1.10344015 |
| 73 | MP0003195_calcinosis | 1.08474481 |
| 74 | MP0004133_heterotaxia | 1.06763401 |
| 75 | MP0001324_abnormal_eye_pigmentation | 1.05067893 |
| 76 | MP0005174_abnormal_tail_pigmentation | 1.04014780 |
| 77 | MP0004085_abnormal_heartbeat | 1.02978114 |
| 78 | MP0001986_abnormal_taste_sensitivity | 1.02964854 |
| 79 | MP0001905_abnormal_dopamine_level | 0.99926644 |
| 80 | MP0005377_hearing/vestibular/ear_phenot | 0.99359175 |
| 81 | MP0003878_abnormal_ear_physiology | 0.99359175 |
| 82 | MP0008872_abnormal_physiological_respon | 0.99240816 |
| 83 | MP0002837_dystrophic_cardiac_calcinosis | 0.94974896 |
| 84 | MP0000230_abnormal_systemic_arterial | 0.94891442 |
| 85 | MP0003121_genomic_imprinting | 0.93417012 |
| 86 | MP0004145_abnormal_muscle_electrophysio | 0.91677578 |
| 87 | MP0003634_abnormal_glial_cell | 0.91465942 |
| 88 | * MP0002152_abnormal_brain_morphology | 0.90707745 |
| 89 | MP0003631_nervous_system_phenotype | 0.90386015 |
| 90 | MP0002069_abnormal_eating/drinking_beha | 0.89283983 |
| 91 | MP0002160_abnormal_reproductive_system | 0.88505289 |
| 92 | MP0000026_abnormal_inner_ear | 0.87056561 |
| 93 | MP0004147_increased_porphyrin_level | 0.86499460 |
| 94 | MP0004036_abnormal_muscle_relaxation | 0.86354873 |
| 95 | MP0005410_abnormal_fertilization | 0.85984083 |
| 96 | MP0004043_abnormal_pH_regulation | 0.85392209 |
| 97 | MP0004130_abnormal_muscle_cell | 0.84055806 |
| 98 | MP0000631_abnormal_neuroendocrine_gland | 0.83461106 |
| 99 | MP0005391_vision/eye_phenotype | 0.83042918 |
| 100 | MP0001177_atelectasis | 0.82637313 |
| 101 | MP0005464_abnormal_platelet_physiology | 0.82022596 |
| 102 | MP0003950_abnormal_plasma_membrane | 0.81403799 |
| 103 | MP0003137_abnormal_impulse_conducting | 0.80186129 |
| 104 | MP0005645_abnormal_hypothalamus_physiol | 0.80039315 |
| 105 | MP0003183_abnormal_peptide_metabolism | 0.79043852 |
| 106 | MP0002928_abnormal_bile_duct | 0.75536823 |
| 107 | MP0001963_abnormal_hearing_physiology | 0.74862686 |
| 108 | MP0005187_abnormal_penis_morphology | 0.74757605 |
| 109 | MP0008961_abnormal_basal_metabolism | 0.72402872 |
| 110 | MP0003698_abnormal_male_reproductive | 0.69181505 |
| 111 | MP0003638_abnormal_response/metabolism_ | 0.69050717 |
| 112 | MP0008874_decreased_physiological_sensi | 0.67404411 |
| 113 | MP0005535_abnormal_body_temperature | 0.66596261 |
| 114 | MP0004084_abnormal_cardiac_muscle | 0.66162066 |
| 115 | MP0003283_abnormal_digestive_organ | 0.66084459 |
| 116 | MP0001765_abnormal_ion_homeostasis | 0.65385944 |
| 117 | MP0005389_reproductive_system_phenotype | 0.64450255 |
| 118 | MP0003646_muscle_fatigue | 0.64415017 |
| 119 | MP0005620_abnormal_muscle_contractility | 0.64317404 |
| 120 | MP0006292_abnormal_olfactory_placode | 0.64238274 |
| 121 | MP0008789_abnormal_olfactory_epithelium | 0.63376892 |
| 122 | MP0004742_abnormal_vestibular_system | 0.63216077 |
| 123 | MP0002876_abnormal_thyroid_physiology | 0.61935562 |
| 124 | MP0002332_abnormal_exercise_endurance | 0.61535170 |
| 125 | MP0001664_abnormal_digestion | 0.52782332 |
| 126 | MP0003632_abnormal_nervous_system | 0.51751110 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 8.50849869 |
| 2 | Focal motor seizures (HP:0011153) | 6.06287815 |
| 3 | Myokymia (HP:0002411) | 5.79439725 |
| 4 | Central scotoma (HP:0000603) | 5.73176927 |
| 5 | Bony spicule pigmentary retinopathy (HP:0007737) | 5.29551339 |
| 6 | Abnormal rod and cone electroretinograms (HP:0008323) | 5.02407220 |
| 7 | Epileptic encephalopathy (HP:0200134) | 4.72533004 |
| 8 | Abnormality of macular pigmentation (HP:0008002) | 4.57636307 |
| 9 | Scotoma (HP:0000575) | 4.49328583 |
| 10 | Focal seizures (HP:0007359) | 4.36510116 |
| 11 | Visual hallucinations (HP:0002367) | 4.26607565 |
| 12 | Febrile seizures (HP:0002373) | 4.21693926 |
| 13 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 4.03801786 |
| 14 | Limb dystonia (HP:0002451) | 3.87875865 |
| 15 | Atonic seizures (HP:0010819) | 3.85744867 |
| 16 | Progressive cerebellar ataxia (HP:0002073) | 3.72753870 |
| 17 | Absence seizures (HP:0002121) | 3.56174931 |
| 18 | Decreased central vision (HP:0007663) | 3.46572162 |
| 19 | Chorioretinal atrophy (HP:0000533) | 3.39473923 |
| 20 | Attenuation of retinal blood vessels (HP:0007843) | 3.36804832 |
| 21 | Molar tooth sign on MRI (HP:0002419) | 3.35897482 |
| 22 | Abnormality of midbrain morphology (HP:0002418) | 3.35897482 |
| 23 | Dysdiadochokinesis (HP:0002075) | 3.28782052 |
| 24 | Action tremor (HP:0002345) | 3.27759367 |
| 25 | Pigmentary retinal degeneration (HP:0001146) | 3.27370367 |
| 26 | Pancreatic cysts (HP:0001737) | 3.18674575 |
| 27 | Dialeptic seizures (HP:0011146) | 3.17106189 |
| 28 | Inability to walk (HP:0002540) | 3.15297059 |
| 29 | Polyphagia (HP:0002591) | 3.14691760 |
| 30 | Generalized tonic-clonic seizures (HP:0002069) | 3.12680283 |
| 31 | Dyschromatopsia (HP:0007641) | 3.07049426 |
| 32 | Abnormality of binocular vision (HP:0011514) | 3.06242306 |
| 33 | Diplopia (HP:0000651) | 3.06242306 |
| 34 | Pendular nystagmus (HP:0012043) | 3.03465836 |
| 35 | Depression (HP:0000716) | 3.00848882 |
| 36 | Pancreatic fibrosis (HP:0100732) | 2.99684404 |
| 37 | Severe visual impairment (HP:0001141) | 2.98317885 |
| 38 | Gaze-evoked nystagmus (HP:0000640) | 2.94049858 |
| 39 | Gait imbalance (HP:0002141) | 2.88091006 |
| 40 | True hermaphroditism (HP:0010459) | 2.87275048 |
| 41 | Ankle clonus (HP:0011448) | 2.86236213 |
| 42 | Abolished electroretinogram (ERG) (HP:0000550) | 2.86075853 |
| 43 | Type II diabetes mellitus (HP:0005978) | 2.77176710 |
| 44 | Truncal ataxia (HP:0002078) | 2.73951593 |
| 45 | Nephronophthisis (HP:0000090) | 2.73615847 |
| 46 | Anxiety (HP:0000739) | 2.72651162 |
| 47 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.71458953 |
| 48 | Congenital primary aphakia (HP:0007707) | 2.71219765 |
| 49 | Increased corneal curvature (HP:0100692) | 2.68196581 |
| 50 | Keratoconus (HP:0000563) | 2.68196581 |
| 51 | Broad-based gait (HP:0002136) | 2.65519266 |
| 52 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.65017529 |
| 53 | Hyperventilation (HP:0002883) | 2.64078491 |
| 54 | Dysmetric saccades (HP:0000641) | 2.63474699 |
| 55 | Abnormality of the corticospinal tract (HP:0002492) | 2.63406959 |
| 56 | Pheochromocytoma (HP:0002666) | 2.61524832 |
| 57 | Choroideremia (HP:0001139) | 2.59100242 |
| 58 | Photophobia (HP:0000613) | 2.57347575 |
| 59 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.55623644 |
| 60 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.55623644 |
| 61 | Type II lissencephaly (HP:0007260) | 2.55516752 |
| 62 | Lissencephaly (HP:0001339) | 2.52451589 |
| 63 | Poor eye contact (HP:0000817) | 2.51786803 |
| 64 | Abnormality of alanine metabolism (HP:0010916) | 2.51607175 |
| 65 | Hyperalaninemia (HP:0003348) | 2.51607175 |
| 66 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.51607175 |
| 67 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.50000090 |
| 68 | Thyroid-stimulating hormone excess (HP:0002925) | 2.46044942 |
| 69 | Nephrogenic diabetes insipidus (HP:0009806) | 2.45301898 |
| 70 | Torticollis (HP:0000473) | 2.42650547 |
| 71 | Abnormal eating behavior (HP:0100738) | 2.39288390 |
| 72 | Medial flaring of the eyebrow (HP:0010747) | 2.38989772 |
| 73 | Absent speech (HP:0001344) | 2.37315672 |
| 74 | Impaired social interactions (HP:0000735) | 2.36758507 |
| 75 | Abnormal social behavior (HP:0012433) | 2.36758507 |
| 76 | Retinitis pigmentosa (HP:0000510) | 2.36022850 |
| 77 | Abnormality of the lower motor neuron (HP:0002366) | 2.33449769 |
| 78 | Dysmetria (HP:0001310) | 2.32307719 |
| 79 | Postural instability (HP:0002172) | 2.30916894 |
| 80 | Scanning speech (HP:0002168) | 2.29274650 |
| 81 | Epileptiform EEG discharges (HP:0011182) | 2.29143066 |
| 82 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.28926071 |
| 83 | Progressive inability to walk (HP:0002505) | 2.28288377 |
| 84 | Neuroendocrine neoplasm (HP:0100634) | 2.27743218 |
| 85 | Supranuclear gaze palsy (HP:0000605) | 2.24282584 |
| 86 | Resting tremor (HP:0002322) | 2.24083226 |
| 87 | Protruding tongue (HP:0010808) | 2.23808803 |
| 88 | Impaired smooth pursuit (HP:0007772) | 2.23118865 |
| 89 | Abnormality of the renal medulla (HP:0100957) | 2.19697358 |
| 90 | Agitation (HP:0000713) | 2.19695557 |
| 91 | Dyskinesia (HP:0100660) | 2.19532770 |
| 92 | EEG with generalized epileptiform discharges (HP:0011198) | 2.18578890 |
| 93 | Prolonged QT interval (HP:0001657) | 2.18558396 |
| 94 | Optic nerve hypoplasia (HP:0000609) | 2.18416940 |
| 95 | Focal dystonia (HP:0004373) | 2.16829915 |
| 96 | Hypothermia (HP:0002045) | 2.15250297 |
| 97 | Abnormality of the renal cortex (HP:0011035) | 2.12100077 |
| 98 | Macular degeneration (HP:0000608) | 2.10277791 |
| 99 | Polydipsia (HP:0001959) | 2.09922542 |
| 100 | Abnormal drinking behavior (HP:0030082) | 2.09922542 |
| 101 | Annular pancreas (HP:0001734) | 2.08478849 |
| 102 | Mutism (HP:0002300) | 2.07895147 |
| 103 | Bradykinesia (HP:0002067) | 2.07845261 |
| 104 | Genetic anticipation (HP:0003743) | 2.07658900 |
| 105 | Cystic liver disease (HP:0006706) | 2.07326910 |
| 106 | Prolonged bleeding time (HP:0003010) | 2.05065132 |
| 107 | Amblyopia (HP:0000646) | 2.04177447 |
| 108 | Craniofacial dystonia (HP:0012179) | 2.03864829 |
| 109 | Ventricular fibrillation (HP:0001663) | 2.03437158 |
| 110 | Menorrhagia (HP:0000132) | 2.03187790 |
| 111 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.00748653 |
| 112 | Poor coordination (HP:0002370) | 2.00537875 |
| 113 | Abnormal EKG (HP:0003115) | 1.99747681 |
| 114 | Fair hair (HP:0002286) | 1.99700937 |
| 115 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.98843788 |
| 116 | Decreased circulating renin level (HP:0003351) | 1.96312102 |
| 117 | Drooling (HP:0002307) | 1.96310207 |
| 118 | Excessive salivation (HP:0003781) | 1.96310207 |
| 119 | Pachygyria (HP:0001302) | 1.96156162 |
| 120 | Urinary urgency (HP:0000012) | 1.96033893 |
| 121 | Specific learning disability (HP:0001328) | 1.95563208 |
| 122 | Renal cortical cysts (HP:0000803) | 1.95449005 |
| 123 | Exercise-induced myalgia (HP:0003738) | 1.94634024 |
| 124 | Spastic tetraplegia (HP:0002510) | 1.94354297 |
| 125 | Hyperlipoproteinemia (HP:0010980) | 1.93966921 |
| 126 | Vaginal atresia (HP:0000148) | 1.93856816 |
| 127 | Cholecystitis (HP:0001082) | 1.93427560 |
| 128 | Abnormal gallbladder physiology (HP:0012438) | 1.93427560 |
| 129 | Spastic gait (HP:0002064) | 1.93039650 |
| 130 | Hypsarrhythmia (HP:0002521) | 1.92838345 |
| 131 | Hemiparesis (HP:0001269) | 1.92532064 |
| 132 | Genital tract atresia (HP:0001827) | 1.92297289 |
| 133 | Constricted visual fields (HP:0001133) | 1.92093235 |
| 134 | 3-Methylglutaconic aciduria (HP:0003535) | 1.90228938 |
| 135 | Congenital, generalized hypertrichosis (HP:0004540) | 1.89877024 |
| 136 | Status epilepticus (HP:0002133) | 1.89124289 |
| 137 | Clumsiness (HP:0002312) | 1.88282334 |
| 138 | Hemiplegia (HP:0002301) | 1.87886639 |
| 139 | Impaired vibratory sensation (HP:0002495) | 1.86594211 |
| 140 | Hypoventilation (HP:0002791) | 1.86016850 |
| 141 | Abnormal ciliary motility (HP:0012262) | 1.82958865 |
| 142 | Incomplete penetrance (HP:0003829) | 1.82504936 |
| 143 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.81213150 |
| 144 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.81213150 |
| 145 | Chronic hepatic failure (HP:0100626) | 1.80369341 |
| 146 | Absent/shortened dynein arms (HP:0200106) | 1.79751399 |
| 147 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.79751399 |
| 148 | Widely spaced teeth (HP:0000687) | 1.79278484 |
| 149 | Lower limb muscle weakness (HP:0007340) | 1.78636230 |
| 150 | Sleep apnea (HP:0010535) | 1.78323172 |
| 151 | Generalized hypopigmentation of hair (HP:0011358) | 1.77557392 |
| 152 | Posterior subcapsular cataract (HP:0007787) | 1.77078514 |
| 153 | Stereotypic behavior (HP:0000733) | 1.75150512 |
| 154 | Optic disc pallor (HP:0000543) | 1.73280995 |
| 155 | Retinal dysplasia (HP:0007973) | 1.71299077 |
| 156 | Intention tremor (HP:0002080) | 1.70474796 |
| 157 | Abnormality of the labia minora (HP:0012880) | 1.70148019 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.57203590 |
| 2 | NTRK3 | 3.80258470 |
| 3 | FRK | 3.46466209 |
| 4 | MAP3K9 | 3.03699965 |
| 5 | MAP3K4 | 3.00785594 |
| 6 | CASK | 2.78206050 |
| 7 | MINK1 | 2.57528659 |
| 8 | DAPK2 | 2.52982783 |
| 9 | ADRBK2 | 2.51097367 |
| 10 | MAP2K7 | 2.42227777 |
| 11 | TAOK3 | 2.37721011 |
| 12 | PAK6 | 2.27490447 |
| 13 | PRPF4B | 2.24035616 |
| 14 | BMPR1B | 2.23433409 |
| 15 | NEK1 | 2.07379985 |
| 16 | MARK1 | 2.04080632 |
| 17 | PRKD3 | 2.02704955 |
| 18 | KSR2 | 1.98460865 |
| 19 | WNK3 | 1.98195146 |
| 20 | CAMKK1 | 1.92608171 |
| 21 | PNCK | 1.91712970 |
| 22 | MAP3K12 | 1.87156921 |
| 23 | DAPK1 | 1.72397740 |
| 24 | DYRK2 | 1.71327074 |
| 25 | KSR1 | 1.63201254 |
| 26 | ZAK | 1.63139958 |
| 27 | WNK4 | 1.58479527 |
| 28 | NTRK2 | 1.57732097 |
| 29 | CAMKK2 | 1.56485079 |
| 30 | PLK2 | 1.55582272 |
| 31 | MAP2K4 | 1.55438160 |
| 32 | ARAF | 1.55001500 |
| 33 | MAP4K2 | 1.51149950 |
| 34 | SGK494 | 1.47509653 |
| 35 | SGK223 | 1.47509653 |
| 36 | CDK5 | 1.46426521 |
| 37 | STK38 | 1.42573609 |
| 38 | TLK1 | 1.39623408 |
| 39 | SGK2 | 1.37472133 |
| 40 | CDK19 | 1.36738511 |
| 41 | GRK5 | 1.34675036 |
| 42 | NTRK1 | 1.29782454 |
| 43 | PINK1 | 1.27881820 |
| 44 | RIPK4 | 1.26327731 |
| 45 | GRK1 | 1.26321515 |
| 46 | PRKCG | 1.24351810 |
| 47 | FES | 1.22103361 |
| 48 | SIK3 | 1.19137513 |
| 49 | AKT3 | 1.18472395 |
| 50 | ACVR1B | 1.12796224 |
| 51 | CSNK1G2 | 1.10635157 |
| 52 | MAP3K13 | 1.09227111 |
| 53 | PHKG2 | 1.06868538 |
| 54 | PHKG1 | 1.06868538 |
| 55 | SGK3 | 1.04354391 |
| 56 | CDK18 | 1.04055223 |
| 57 | TRIM28 | 1.02021258 |
| 58 | MAPK13 | 1.00881445 |
| 59 | PRKCH | 1.00231821 |
| 60 | TNIK | 0.99492481 |
| 61 | LMTK2 | 0.98853535 |
| 62 | CDK15 | 0.97714283 |
| 63 | CDK14 | 0.96420973 |
| 64 | CSNK1G3 | 0.95559426 |
| 65 | CAMK2A | 0.94826324 |
| 66 | PKN1 | 0.93375482 |
| 67 | SIK2 | 0.92636378 |
| 68 | DYRK1A | 0.90296399 |
| 69 | CCNB1 | 0.88112228 |
| 70 | CSNK1G1 | 0.87736864 |
| 71 | TXK | 0.85129405 |
| 72 | MAPKAPK3 | 0.84943359 |
| 73 | CAMK1 | 0.84300580 |
| 74 | CDK11A | 0.82927878 |
| 75 | MAP3K2 | 0.81925112 |
| 76 | EPHA3 | 0.80959517 |
| 77 | NME1 | 0.80526298 |
| 78 | TNK2 | 0.79936521 |
| 79 | NUAK1 | 0.77416766 |
| 80 | PBK | 0.74900798 |
| 81 | LIMK1 | 0.74790412 |
| 82 | RAF1 | 0.72687928 |
| 83 | PTK2B | 0.71617350 |
| 84 | MAPKAPK5 | 0.71415094 |
| 85 | UHMK1 | 0.68742254 |
| 86 | SGK1 | 0.67659809 |
| 87 | BRAF | 0.67445665 |
| 88 | CAMK2D | 0.67353469 |
| 89 | MYLK | 0.66358450 |
| 90 | FER | 0.66186485 |
| 91 | BCR | 0.65962604 |
| 92 | PRKCE | 0.65800138 |
| 93 | RET | 0.65518606 |
| 94 | OXSR1 | 0.64785482 |
| 95 | CSNK1A1L | 0.64557028 |
| 96 | CAMK2B | 0.62263396 |
| 97 | TAOK1 | 0.61420914 |
| 98 | NEK6 | 0.61303604 |
| 99 | BMPR2 | 0.60130396 |
| 100 | PIK3CA | 0.59404031 |
| 101 | MAP2K1 | 0.59232446 |
| 102 | RIPK1 | 0.57103617 |
| 103 | PAK3 | 0.56592023 |
| 104 | TYRO3 | 0.56320152 |
| 105 | STK11 | 0.55822838 |
| 106 | RPS6KA3 | 0.55391880 |
| 107 | CDC42BPA | 0.55186352 |
| 108 | PRKCZ | 0.54148857 |
| 109 | MAP3K1 | 0.52845441 |
| 110 | SYK | 0.52623565 |
| 111 | RPS6KA5 | 0.52104489 |
| 112 | PDK1 | 0.50854553 |
| 113 | CAMK4 | 0.50152077 |
| 114 | CSNK1D | 0.49116568 |
| 115 | PDK3 | 0.49015362 |
| 116 | PDK4 | 0.49015362 |
| 117 | ADRBK1 | 0.48911561 |
| 118 | BRSK1 | 0.48553206 |
| 119 | DAPK3 | 0.48336568 |
| 120 | MARK2 | 0.46797422 |
| 121 | PRKCQ | 0.46588685 |
| 122 | PDPK1 | 0.46553166 |
| 123 | STK39 | 0.45808476 |
| 124 | FGFR2 | 0.45629155 |
| 125 | PRKCB | 0.44901693 |
| 126 | CAMK2G | 0.44858794 |
| 127 | WNK1 | 0.44690921 |
| 128 | INSRR | 0.44239372 |
| 129 | MAPK12 | 0.43457620 |
| 130 | MAPK10 | 0.42981840 |
| 131 | PRKCA | 0.42547881 |
| 132 | TSSK6 | 0.42048561 |
| 133 | PRKG1 | 0.41898323 |
| 134 | TGFBR1 | 0.41748039 |
| 135 | RPS6KA2 | 0.41315560 |
| 136 | TAOK2 | 0.39206529 |
| 137 | MAP3K7 | 0.39073575 |
| 138 | VRK1 | 0.38996530 |
| 139 | CSNK1A1 | 0.38894963 |
| 140 | PRKACA | 0.38699837 |
| 141 | CAMK1G | 0.37589662 |
| 142 | PRKCI | 0.37587580 |
| 143 | TEC | 0.35293255 |
| 144 | BMX | 0.34277348 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 5.14988239 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.90494818 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 3.51542044 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 3.12650809 |
| 5 | * GABAergic synapse_Homo sapiens_hsa04727 | 2.81728914 |
| 6 | * Morphine addiction_Homo sapiens_hsa05032 | 2.64685610 |
| 7 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.59759133 |
| 8 | * Circadian entrainment_Homo sapiens_hsa04713 | 2.55219372 |
| 9 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 2.15154504 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.13305848 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 2.09946370 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.07365309 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.06713897 |
| 14 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 2.04472262 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 2.00532476 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.94333246 |
| 17 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.90709767 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 1.90153014 |
| 19 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.84433605 |
| 20 | Renin secretion_Homo sapiens_hsa04924 | 1.66509898 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.62579421 |
| 22 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.60950892 |
| 23 | Taste transduction_Homo sapiens_hsa04742 | 1.60071741 |
| 24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.58252927 |
| 25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.56431739 |
| 26 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.49104252 |
| 27 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.48816723 |
| 28 | * Serotonergic synapse_Homo sapiens_hsa04726 | 1.46369428 |
| 29 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.46338632 |
| 30 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.44528273 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.40983723 |
| 32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.35334040 |
| 33 | Long-term depression_Homo sapiens_hsa04730 | 1.33333883 |
| 34 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.30996720 |
| 35 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.28095068 |
| 36 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.26210512 |
| 37 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.25919728 |
| 38 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.21940653 |
| 39 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.20520373 |
| 40 | Gap junction_Homo sapiens_hsa04540 | 1.19838390 |
| 41 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.17634783 |
| 42 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.17262309 |
| 43 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.12919267 |
| 44 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.09682453 |
| 45 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.08503024 |
| 46 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.07404068 |
| 47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.06546099 |
| 48 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.05069542 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.02542062 |
| 50 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.98898336 |
| 51 | Circadian rhythm_Homo sapiens_hsa04710 | 0.98848934 |
| 52 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.97385283 |
| 53 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.97034573 |
| 54 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.96029035 |
| 55 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.93209087 |
| 56 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.88560642 |
| 57 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.82057619 |
| 58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81111079 |
| 59 | Glioma_Homo sapiens_hsa05214 | 0.80225366 |
| 60 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.80118281 |
| 61 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.78315738 |
| 62 | Platelet activation_Homo sapiens_hsa04611 | 0.76616488 |
| 63 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.73462293 |
| 64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73223298 |
| 65 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.71509901 |
| 66 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.71493679 |
| 67 | Melanogenesis_Homo sapiens_hsa04916 | 0.71032249 |
| 68 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.70129539 |
| 69 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.68123122 |
| 70 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.68086465 |
| 71 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.67910554 |
| 72 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.67787812 |
| 73 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.65109204 |
| 74 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.64816881 |
| 75 | Huntingtons disease_Homo sapiens_hsa05016 | 0.63308506 |
| 76 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.62634137 |
| 77 | Axon guidance_Homo sapiens_hsa04360 | 0.62624984 |
| 78 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.62583086 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.62119072 |
| 80 | ABC transporters_Homo sapiens_hsa02010 | 0.60699404 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60380465 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.60301688 |
| 83 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.59945841 |
| 84 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.59945629 |
| 85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58834115 |
| 86 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.58155148 |
| 87 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.57852236 |
| 88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56822121 |
| 89 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56596372 |
| 90 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55901439 |
| 91 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.55141226 |
| 92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53584500 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53560451 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53385467 |
| 95 | * Alcoholism_Homo sapiens_hsa05034 | 0.51260852 |
| 96 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.46670581 |
| 97 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.45770697 |
| 98 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45323278 |
| 99 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.44904585 |
| 100 | Basal transcription factors_Homo sapiens_hsa03022 | 0.43690187 |
| 101 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43562180 |
| 102 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43081681 |
| 103 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.42596655 |
| 104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.42303574 |
| 105 | Peroxisome_Homo sapiens_hsa04146 | 0.41851380 |
| 106 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.41104672 |
| 107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39381728 |
| 108 | Endometrial cancer_Homo sapiens_hsa05213 | 0.39142538 |
| 109 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.38879335 |
| 110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38257299 |
| 111 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.38027221 |
| 112 | Endocytosis_Homo sapiens_hsa04144 | 0.37943648 |
| 113 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.37645524 |
| 114 | Alzheimers disease_Homo sapiens_hsa05010 | 0.37529042 |
| 115 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.37488673 |
| 116 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.37221722 |
| 117 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.36564205 |
| 118 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.36514183 |
| 119 | Retinol metabolism_Homo sapiens_hsa00830 | 0.36085358 |
| 120 | Histidine metabolism_Homo sapiens_hsa00340 | 0.35792494 |
| 121 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.35738784 |
| 122 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.34773959 |
| 123 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.34700117 |
| 124 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.32445304 |
| 125 | Parkinsons disease_Homo sapiens_hsa05012 | 0.31995062 |
| 126 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.31923885 |
| 127 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.31712929 |
| 128 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31191510 |
| 129 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.30746560 |
| 130 | RNA polymerase_Homo sapiens_hsa03020 | 0.30284093 |
| 131 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.30005606 |
| 132 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.28935196 |
| 133 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28155621 |
| 134 | Bile secretion_Homo sapiens_hsa04976 | 0.27259812 |
| 135 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.26867434 |
| 136 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.26840551 |
| 137 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.26479834 |
| 138 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.23512348 |
| 139 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.23458042 |
| 140 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.23127030 |
| 141 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.22802442 |

